Xingrui Li

1.5k total citations
45 papers, 1.1k citations indexed

About

Xingrui Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xingrui Li has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Xingrui Li's work include Ferroptosis and cancer prognosis (8 papers), RNA modifications and cancer (8 papers) and Cancer-related molecular mechanisms research (7 papers). Xingrui Li is often cited by papers focused on Ferroptosis and cancer prognosis (8 papers), RNA modifications and cancer (8 papers) and Cancer-related molecular mechanisms research (7 papers). Xingrui Li collaborates with scholars based in China, United States and Germany. Xingrui Li's co-authors include Ge-Ge Wu, Xin‐Wu Cui, Qi Wei, Christoph F. Dietrich, Liqiang Zhou, Xinglong Wu, Lingyun Bao, Hua-Rong Ye, Youbin Deng and Shuyan Huang and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Oncogene and Radiology.

In The Last Decade

Xingrui Li

43 papers receiving 1.0k citations

Peers

Xingrui Li
Maeve Mullooly Ireland
Qinghua Cao China
Rachel L. Stewart United States
Mariarosaria Incoronato Italy
Ji Hyun Chang South Korea
Shaolei Lu United States
Manohar Pradhan Norway
Glenn Francis Australia
Maeve Mullooly Ireland
Xingrui Li
Citations per year, relative to Xingrui Li Xingrui Li (= 1×) peers Maeve Mullooly

Countries citing papers authored by Xingrui Li

Since Specialization
Citations

This map shows the geographic impact of Xingrui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingrui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingrui Li more than expected).

Fields of papers citing papers by Xingrui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingrui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingrui Li. The network helps show where Xingrui Li may publish in the future.

Co-authorship network of co-authors of Xingrui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xingrui Li. A scholar is included among the top collaborators of Xingrui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingrui Li. Xingrui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qiang, et al.. (2024). A prognostic model based on CLEC6A predicts clinical outcome of breast cancer patients. International Immunopharmacology. 137. 112411–112411. 1 indexed citations
2.
Wang, Jun, Huimin Zhang, Guanhua Zhu, et al.. (2024). STT3-mediated aberrant N-glycosylation of CD24 inhibits paclitaxel sensitivity in triple-negative breast cancer. Acta Pharmacologica Sinica. 46(4). 1097–1110. 3 indexed citations
3.
Li, Shuyu, Nan Zhang, Hao Zhang, et al.. (2024). Deciphering the TCF19/miR-199a-5p/SP1/LOXL2 pathway: Implications for breast cancer metastasis and epithelial-mesenchymal transition. Cancer Letters. 597. 216995–216995. 1 indexed citations
4.
Wang, Ge, Yaying Du, Tao Xu, et al.. (2024). Directed differentiation of human embryonic stem cells into parathyroid cells and establishment of parathyroid organoids. Cell Proliferation. 57(8). e13634–e13634. 4 indexed citations
5.
Yang, Xue, Yonglin Wu, Hanning Li, et al.. (2023). Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery. BMC Endocrine Disorders. 23(1). 113–113. 6 indexed citations
6.
7.
Chen, Li, Yihang Qi, Xiangyi Kong, et al.. (2022). Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy. Frontiers in Nutrition. 8. 786742–786742. 16 indexed citations
8.
Yang, Xue, Ge Wang, Hanning Li, et al.. (2022). Regulation of antitumor miR-205 targets oncogenes: Direct regulation of lymphoid specific helicase and its clinical significance. Life Sciences. 309. 120993–120993. 1 indexed citations
9.
Li, Hanning, Xiang Zhou, Ge Wang, et al.. (2021). CAR-T Cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 107(4). 1110–1126. 27 indexed citations
10.
11.
He, Xiao, Tao Xu, Weijie Hu, et al.. (2021). Circular RNAs: Their Role in the Pathogenesis and Orchestration of Breast Cancer. Frontiers in Cell and Developmental Biology. 9. 647736–647736. 28 indexed citations
12.
Ming, Jie, Jingqiang Zhu, Hao Zhang, et al.. (2021). A multicenter, prospective study to observe the initial management of patients with differentiated thyroid cancer in China (DTCC study). BMC Endocrine Disorders. 21(1). 208–208. 10 indexed citations
13.
Li, Hanning, Yaying Du, Tao Xu, et al.. (2020). TMEM158 May Serve as a Diagnostic Biomarker for Anaplastic Thyroid Carcinoma: An Integrated Bioinformatic Analysis. Current Medical Science. 40(6). 1137–1147. 4 indexed citations
14.
Li, Juanjuan, Cesar Augusto Santa-Maria, Pengcheng Zhang, et al.. (2020). Patient-reported Outcomes of Patients With Breast Cancer During the COVID-19 Outbreak in the Epicenter of China: A Cross-sectional Survey Study. Clinical Breast Cancer. 20(5). e651–e662. 94 indexed citations
15.
Zhou, Liqiang, Xinglong Wu, Shuyan Huang, et al.. (2019). Lymph Node Metastasis Prediction from Primary Breast Cancer US Images Using Deep Learning. Radiology. 294(1). 19–28. 254 indexed citations
16.
Zhang, Jinjun, Yaying Du, Xiaoxue Zhang, Mengchen Li, & Xingrui Li. (2018). Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways. Journal of Cancer. 9(7). 1318–1328. 31 indexed citations
17.
Du, Yaying, Wenfei Xia, Jinjun Zhang, et al.. (2017). Comprehensive analysis of long noncoding RNA–mRNA co-expression patterns in thyroid cancer. Molecular BioSystems. 13(10). 2107–2115. 22 indexed citations
18.
Li, Xingrui, et al.. (2010). Efficient Treg depletion induces T‐cell infiltration and rejection of large tumors. European Journal of Immunology. 40(12). 3325–3335. 103 indexed citations
19.
Ma, Xiaopeng, et al.. (2009). A novel immunotherapy to hepatocellular carcinoma: CD40-activated B lymphocytes transfected with AFPmRNA. Medical Hypotheses. 73(5). 835–837. 3 indexed citations
20.
Mi, Denghai, et al.. (2006). Relationsip between PTEN and VEGF expression and clinicopathological characteristics in HCC. Journal of Huazhong University of Science and Technology [Medical Sciences]. 26(6). 682–685. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maeve Mullooly Breakdown of academic impact, for papers by Qinghua Cao Breakdown of academic impact, for papers by Rachel L. Stewart Breakdown of academic impact, for papers by Mariarosaria Incoronato Breakdown of academic impact, for papers by Ji Hyun Chang Breakdown of academic impact, for papers by Shaolei Lu Breakdown of academic impact, for papers by Manohar Pradhan Breakdown of academic impact, for papers by Glenn Francis
Rankless by CCL
2026